The Biomedical Research for the 21st Century (BioMed21) Collaboration initially grew out of a 2015 review publication authored by a diverse group of eminent scientists who recognized the translational limitations of the current paradigm in biomedical research and drug discovery built on animal models, and the need for change. 

Our international team of scientists, policy specialists and communication experts are passionate about scientific progress. Whilst the past century has seen life-changing scientific developments in several areas of biomedical research, we know there is more work to be done. Emerging infectious diseases are on the rise, cancer rates and mental health disorders are rapidly increasing, and there remains health conditions that have no effective treatments, let alone cures. We believe that the development and integration of New Approach Methodologies (NAMs) such as microphysiological systems, computational methods, and bioprinting can offer researchers new and powerful tools to tackle the major human health challenges of this century, whilst putting science on a path to eliminating the use of animals in laboratories.

Biomed21s long-term vision will benefit many. Patients of today and tomorrow can be supported through our attainable policy goals, scientific and educational projects, publications, and funding. The benefit to animals is also considerable, as increased use of NAMs in biomedical research will lead to a decline in the number of animals in research laboratories.

Respect, dialogue, and inclusion of diverse viewpoints are core values of the BioMed21 Collaboration, and we work in partnership with academic institutions, governments, charities, agencies and the corporate sector to reach our goals.